(PCOM, PBIO, KTOS) PennyOmega.com Watch List for Thursday Mar. 08, 2012

PCOM, Points International Ltd. ** For the fourth quarter of 2011, PCOM posted total revenue of $32.9 million, a 22% increase year over year and 14% sequentially, while its net income was $2.1 million, or $0.14 per share, compared to net income of $0.3 million, or $0.02 per share, in the same period the prior year and net income of $1.7 million, or $0.11 per share, in the prior quarter. PCOM, conducting business as Points.com, is the global leader in reward currency management, providing multiple eCommerce and technology solutions to the world’s leading loyalty brands. Points.com also manages www.points.com, the largest consumer rewards management platform that allows over 3 million users to trade, exchange and redeem points, miles and rewards. More about PCOM at www.pointsinternational.com ******************* PBIO, Pressure BioSciences, Inc. ** PBIO reported that data supporting important advantages of its powerful and enabling Pressure Cycling Technology Platform were presented last week at the 56th Annual Meeting of the Biophysical Society and this week at the 8th Annual US Human Proteomic Organization Conference. The development of highly sophisticated analytical tools for the research laboratory has enabled a greater understanding of complex biological molecules, including proteins. One such method, Electron Paramagnetic Resonance (“EPR”) spectroscopy, has been shown to provide key information on the structure, flexibility, and function of proteins. This information is crucial to the development of new therapeutics, vaccines, and diagnostics. – At the Biophysical Society Annual Meeting, researchers reported the development of a specially-designed, pressure-based EPR system that uses rapid changes in pressure to monitor the rate of protein conformational changes likely related to a protein’s function. This strategy allows the investigation of dynamic events that would be difficult or impossible to study by conventional EPR technology. – At the US Human Proteomic Organization Conference, PBIO’s Vice President of Research and Development reported on the benefits of the application of high pressure in sample preparation for proteomic research directed towards the discovery of protein biomarkers for human disease. Data from the study indicated that pressure-enhanced sample preparation can help to discover proteins that have been traditionally difficult to detect. PBIO is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology, which uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. More about PBIO at www.pressurebiosciences.com ******************* KTOS, Kratos Defense & Security Solutions, Inc. ** For the fiscal year 2011, KTOS posted revenues of $723.1 million, a 77% increase year over year, and Adjusted EBITDA of $91.8 million, a 131% increase over fiscal year 2010. KTOS is providing for its fiscal 2012, revenue guidance of approximately $950 million to $1 billion, Adjusted EBITDA guidance of approximately $120 million to $130 million, and Adjusted Free Cash Flow guidance of approximately $50 million to $65 million. KTOS is a specialized National Security technology business providing mission critical products, services and solutions for United States National Security priorities. KTOS’ core capabilities are sophisticated engineering, manufacturing and system integration offerings for National Security platforms and programs. KTOS’ areas of expertise include Command, Control, Communications, Computing, Combat Systems, Intelligence, Surveillance and Reconnaissance (C5ISR), satellite communication systems, unmanned systems, cyber warfare, cyber security, information assurance, critical infrastructure security and weapons systems sustainment. More about KTOS at www.KratosDefense.com. ******************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.